Waystar Holding Corp. (WAY) Peer Comparison
$28.85
$-0.13
(-0.45%)
As on 23-Oct-2026 16:00EDT
Market cap
$5,532 Mln
Revenue (TTM)
$1,206 Mln
P/E Ratio
41.2
P/B Ratio
2.3
Div. Yield
0 %
Edit
| Waystar Holding Corp. (WAY) | Life360, Inc. (LIF) | Westlin Corporation (WSTN) | Morningstar US Mid Cap PR USD (MMCP) | Valion Bio Inc (VBIO) | |
|---|---|---|---|---|---|
Market cap ($ Mln) |
5,532 | 3,685 | 81 | 10 | 2 |
Revenue ($ Mln) |
1,206 | 573 | -- | 4 | 2 |
Net Profit ($ Mln) |
134.79 | 147.29 | 0.89 | -0.12 | -18.75 |
Net Margin (%) |
11.18 | 25.72 | -- | 1.20 | -1,003.19 |
RoE (%) |
3.43 | 25.36 | 4.09 | 54.17 | -130.74 |
Price to Earnings |
41.21 | 26.30 | 68.07 | -- | -- |
Price-To-Book |
2.30 | 5.52 | -- | 1,802.81 | 0.52 |
Income Statement ($ Mln)
| Waystar Holding Corp. (WAY) | Life360, Inc. (LIF) | Westlin Corporation (WSTN) | Morningstar US Mid Cap PR USD (MMCP) | Valion Bio Inc (VBIO) | |
|---|---|---|---|---|---|
|
Operating Revenue
|
1,099.28 | 489.48 | -- | 2.05 | 0.38 |
|
Cost of Revenue
|
348.16 | 108.64 | -- | 1.39 | 0.35 |
|
Gross Profit
|
751.12 | 380.84 | -- | 0.66 | 0.03 |
|
Operating Expenses
|
501.81 | 362.02 | -- | 0.93 | 7.90 |
|
Operating Profit (EBIT)
|
249.31 | 18.83 | -- | -0.27 | -7.90 |
|
Other Income
|
-- | -- | -- | -- | -- |
|
Profit before Tax
|
171.76 | 32.66 | -0.01 | -0.28 | -7.99 |
|
Provision for Tax
|
59.67 | -118.17 | -- | -- | -- |
|
Profit after Tax (Net Income)
|
112.09 | 150.83 | -0.01 | -0.28 | -8.88 |
|
Minority Interest
|
-- | -- | -- | -- | -- |
|
Consolidated Profit
|
-- | -- | -- | -- | -- |
Liabilities ($ Mln)
| Waystar Holding Corp. (WAY) | Life360, Inc. (LIF) | Westlin Corporation (WSTN) | Morningstar US Mid Cap PR USD (MMCP) | Valion Bio Inc (VBIO) | |
|---|---|---|---|---|---|
|
Shareholder's Funds
|
3,878.83 | 548.18 | 0.02 | -0.17 | 16.80 |
|
Minority Interest
|
-- | -- | -- | -- | -- |
|
Non-Current Liabilities
|
1,688.21 | 314.72 | 0.00 | 0.37 | 14.16 |
|
Current Liabilities
|
218.06 | 96.79 | 0.18 | 0.51 | 0.65 |
|
Total Liabilities
|
5,785.10 | 959.69 | 0.20 | 0.71 | 31.61 |
Assets ($ Mln)
| Waystar Holding Corp. (WAY) | Life360, Inc. (LIF) | Westlin Corporation (WSTN) | Morningstar US Mid Cap PR USD (MMCP) | Valion Bio Inc (VBIO) | |
|---|---|---|---|---|---|
|
Non-Current Assets
|
5,476.69 | 353.58 | 0.20 | 0.26 | 18.60 |
|
Current Assets
|
308.41 | 606.10 | 0.00 | 0.45 | 13.01 |
|
Total Assets
|
5,785.10 | 959.69 | -- | 0.71 | 31.61 |
|
Total Debt*
|
1,490.93 | 310.75 | -- | 0.35 | 6.45 |
|
Net Current Assets
|
90.35 | 509.31 | -0.18 | -0.14 | 12.36 |
Cashflow ($ Mln)
| Waystar Holding Corp. (WAY) | Life360, Inc. (LIF) | Westlin Corporation (WSTN) | Morningstar US Mid Cap PR USD (MMCP) | Valion Bio Inc (VBIO) | |
|---|---|---|---|---|---|
|
Cash From Operating Activities
|
309.67 | 88.63 | -- | -0.21 | -7.00 |
|
Cash Flow from Investing Activities
|
-680.90 | -35.33 | -- | -- | -0.71 |
|
Cash from Financing Activities
|
243.45 | 282.07 | -- | 0.16 | 18.35 |
|
Net Cash Inflow / Outflow
|
-- | -- | -- | -- | -- |
Ratios
Profitability Ratios
| Waystar Holding Corp. (WAY) | Life360, Inc. (LIF) | Westlin Corporation (WSTN) | Morningstar US Mid Cap PR USD (MMCP) | Valion Bio Inc (VBIO) | |
|---|---|---|---|---|---|
|
ROCE (%)
|
2.31 | 24.76 | -- | -2,636.14 | -68.86 |
|
ROE (%)
|
3.22 | 33.27 | -- | 170.10 | -91.85 |
|
ROA (%)
|
2.16 | 21.53 | -- | -39.73 | -51.60 |
|
EBIT Margin (%)
|
-- | -- | -- | -- | -- |
|
Net Margin (%)
|
10.20 | 30.81 | -- | -13.81 | -2,324.08 |
|
Cash Profit Margin (%)
|
-- | -- | -- | -- | -- |
Growth Ratios
| Waystar Holding Corp. (WAY) | Life360, Inc. (LIF) | Westlin Corporation (WSTN) | Morningstar US Mid Cap PR USD (MMCP) | Valion Bio Inc (VBIO) | |
|---|---|---|---|---|---|
|
Revenue Growth (%)
|
0.17 | 0.32 | -- | 0.00 | -1.00 |
|
EBIT Growth (%)
|
-- | -- | -- | -- | -- |
|
Net Profit Growth (%)
|
686.09 | 3,411.35 | -- | 0.00 | -56.99 |
|
EPS Growth (%)
|
6.32 | 33.35 | -- | -- | -2.94 |
|
Book Value Growth (%)
|
-- | -- | -- | -- | -- |
Valuation Ratios
| Waystar Holding Corp. (WAY) | Life360, Inc. (LIF) | Westlin Corporation (WSTN) | Morningstar US Mid Cap PR USD (MMCP) | Valion Bio Inc (VBIO) | |
|---|---|---|---|---|---|
|
Price / Earnings
|
57.66 | 36.22 | -- | -- | -0.04 |
|
Price / Book Value
|
1.67 | 9.97 | -- | -- | 0.02 |
|
Dividend Yield (%)
|
-- | -- | -- | -- | -- |
|
EV/EBITDA
|
20.18 | 113.94 | -- | -- | 0.75 |
|
Market Cap ($ Cr)
|
-- | -- | -- | -- | -- |
Solvency Ratios
| Waystar Holding Corp. (WAY) | Life360, Inc. (LIF) | Westlin Corporation (WSTN) | Morningstar US Mid Cap PR USD (MMCP) | Valion Bio Inc (VBIO) | |
|---|---|---|---|---|---|
|
Debt to Equity
|
0.38 | 0.57 | -- | -2.13 | 0.38 |
|
Short term debt to equity ratio
|
0.01 | 0.00 | -- | -0.75 | 0.03 |
|
Current Ratio
|
1.41 | 6.26 | 0.00 | 0.88 | 20.13 |
|
Quick Ratio
|
-- | 6.16 | -- | -- | 8.53 |
|
Interest Coverage
|
3.22 | -- | -- | -31.30 | -53.75 |
Operating Efficiency Ratios
| Waystar Holding Corp. (WAY) | Life360, Inc. (LIF) | Westlin Corporation (WSTN) | Morningstar US Mid Cap PR USD (MMCP) | Valion Bio Inc (VBIO) | |
|---|---|---|---|---|---|
|
Debtors to sales (%)
|
16.69 | 16.94 | -- | -- | 0.26 |
|
Asset Turnover
|
0.21 | 0.70 | -- | 2.88 | 0.02 |
|
Receivable days
|
55.08 | 53.89 | -- | -- | 33.47 |
|
Inventory Days
|
-15.38 | 30.13 | -- | -- | 332.90 |
|
Payable days
|
51.57 | 23.32 | -- | 80.44 | 202.97 |
|
Cash Conversion Cycle
|
-14.70 | 60.70 | -- | -- | 163.39 |
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
loading...
loading...
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.
